2018
DOI: 10.1016/j.neurobiolaging.2018.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Targeted exome sequencing reveals homozygous TREM2 R47C mutation presenting with behavioral variant frontotemporal dementia without bone involvement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
17
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 14 publications
(18 citation statements)
references
References 25 publications
1
17
0
Order By: Relevance
“…The 6 families affected in this pedigree may benefit from clinical evaluation and testing with plasma GRN, which is indicated for screening possible GRN mutation carriers, especially that all mutation carriers in this family have low plasma GRN levels [39]. This R110X mutation and the 2 novel pathogenic GRN mutations recently documented in 3 Filipinos [40] suggest that there may be more to be found. It could be prudent in the Philippines to consider plasma GRN as an additional test in the evaluation of dementia with atypical presentation and with positive family history, whether early or late onset, and then do further genetic testing afterward.…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…The 6 families affected in this pedigree may benefit from clinical evaluation and testing with plasma GRN, which is indicated for screening possible GRN mutation carriers, especially that all mutation carriers in this family have low plasma GRN levels [39]. This R110X mutation and the 2 novel pathogenic GRN mutations recently documented in 3 Filipinos [40] suggest that there may be more to be found. It could be prudent in the Philippines to consider plasma GRN as an additional test in the evaluation of dementia with atypical presentation and with positive family history, whether early or late onset, and then do further genetic testing afterward.…”
Section: Discussionmentioning
confidence: 94%
“…This R110X mutation and the 2 novel pathogenic GRN mutations recently documented in 3 Filipinos [40] suggest that there may be more to be found. It could be prudent in the Philippines to consider plasma GRN as an additional test in the evaluation of dementia with atypical presentation and with positive family history, whether early or late onset, and then do further genetic testing afterward.…”
Section: Discussionmentioning
confidence: 95%
“…TREM2 and TYROBP (encoding DAP12), which together encode a receptor signaling complex expressed in myeloid cells, were first linked to autosomal-recessive Nasu-Hakola disease (NHD; also known as polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy) more than 15 years ago [57,58]. Although NHD classically involves early-onset dementia and recurrent bone fractures, a number of patients with FTD-like syndromes lacking a bone phenotype (often with early-onset symptoms) have also been identified who harbor homozygous or compound heterozygous mutations in TREM2 [59][60][61][62][63][64][65]. Moreover, a recent meta-analysis of rare TREM2 variants found that variants p.R47H (rs75932628) and p.T96K (rs2234253) confer an ~2-3-fold increase in risk for FTD in European populations [66]; p.R47H is also a well known AD risk factor [67] and a possible risk factor for PD [68].…”
Section: Trem2 and Tyrobpmentioning
confidence: 99%
“…Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) is an innate immune receptor found on myeloid-lineage immune cells, including dendritic cells, monocytes, and tissue-resident macrophages such as osteoclasts in bone and microglia in the brain (1). Heterozygous variants including R47H and R62H are risk factors for Alzheimer's disease (AD), while homozygous loss-of-function in TREM2 causes Nasu-Hakola disease, a severe, early-onset demyelinating dementia presenting as a frontotemporal dementia (FTD) syndrome with cystic bone lesions (2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13).…”
Section: Introductionmentioning
confidence: 99%